FACT

Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore

Retrieved on: 
Dienstag, Mai 7, 2024
Hope, Doctor of Philosophy, FACT, Small claims court, Central Waqf Council, Collection, MOH, Singapore Exchange, Medicine, Ministry, Accreditation, Temperature, Letter, Growth, Operation

Cordlife has also extended the same offer to affected clients with cord blood units stored in Tank 6 and the dry shipper.

Key Points: 
  • Cordlife has also extended the same offer to affected clients with cord blood units stored in Tank 6 and the dry shipper.
  • Singapore Exchange Mainboard-listed Cordlife operates Asia's largest network of private cord blood banks with stem cell storage facilities in six markets, including Singapore.
  • Additionally, Cordlife continues its recruitment efforts to further enhance in-house technical expertise and improve clinical governance standards by adding more lab directors to its team.
  • This demonstrates our unwavering commitment to our stakeholders, including our clients, MOH, business partners, staff and shareholders," Mr Yiu said.

ELFBAR and LOST MARY unveil progress in combatting illicit vapes

Retrieved on: 
Freitag, April 26, 2024
IP, LOST, Law enforcement, FACT, Partnership, Intelligence, Smoking, Crime Stoppers, Convenience, Longevity, Drug

LONDON, April 26, 2024 /PRNewswire/ -- World-leading vaping brands ELFBAR and LOST MARY announced the latest outcomes from their continued global action against counterfeits and crackdown on illicit products.

Key Points: 
  • LONDON, April 26, 2024 /PRNewswire/ -- World-leading vaping brands ELFBAR and LOST MARY announced the latest outcomes from their continued global action against counterfeits and crackdown on illicit products.
  • ELFBAR and LOST MARY are delivering support to the campaigns launched by the Association of Convenience Stores and the Scottish Grocers' Federation — UK's convenience store trade associations.
  • Several millions and counting of counterfeit ELFBAR, EBDESIGN, and LOST MARY vapes have been seized.
  • Tens of thousands of counterfeit ELFBAR and LOST MARY units have since been confiscated in 104 retail stores where illicit products were found.

ELFBAR and LOST MARY unveil progress in combatting illicit vapes

Retrieved on: 
Freitag, April 26, 2024
IP, LOST, Law enforcement, FACT, Partnership, Intelligence, Smoking, Crime Stoppers, Convenience, Longevity, Drug

LONDON, April 26, 2024 /PRNewswire/ -- World-leading vaping brands ELFBAR and LOST MARY announced the latest outcomes from their continued global action against counterfeits and crackdown on illicit products.

Key Points: 
  • LONDON, April 26, 2024 /PRNewswire/ -- World-leading vaping brands ELFBAR and LOST MARY announced the latest outcomes from their continued global action against counterfeits and crackdown on illicit products.
  • ELFBAR and LOST MARY are delivering support to the campaigns launched by the Association of Convenience Stores and the Scottish Grocers' Federation — UK's convenience store trade associations.
  • Several millions and counting of counterfeit ELFBAR, EBDESIGN, and LOST MARY vapes have been seized.
  • Tens of thousands of counterfeit ELFBAR and LOST MARY units have since been confiscated in 104 retail stores where illicit products were found.

NYU Langone's Perlmutter Cancer Center Earns Redesignation as a Comprehensive Cancer Center from the National Cancer Institute

Retrieved on: 
Donnerstag, April 18, 2024
Cancer, Chemoradiotherapy, Lung cancer, Woman, Certification, Epidemiology, Immunotherapy, FACT, NYU Langone Health, Doctor of Philosophy, National Cancer Institute, Research, NYU, Melanoma, Radiation therapy, CCSG, Patient, Faculty, Accreditation, Diagnosis, Messenger, Blood, Alec

NEW YORK, April 18, 2024 /PRNewswire/ -- NYU Langone Health's Laura and Isaac Perlmutter Cancer Center has once again been designated as a Comprehensive Cancer Center, the highest ranking awarded by the National Cancer Institute and further validation that it provides state-of-the-art, research-based approaches to preventing, detecting, and treating cancer.

Key Points: 
  • NEW YORK, April 18, 2024 /PRNewswire/ -- NYU Langone Health's Laura and Isaac Perlmutter Cancer Center has once again been designated as a Comprehensive Cancer Center, the highest ranking awarded by the National Cancer Institute and further validation that it provides state-of-the-art, research-based approaches to preventing, detecting, and treating cancer.
  • Perlmutter Cancer Center is among only 56 institutions recognized across the nation for earning this elite distinction.
  • Perlmutter Cancer Center achieved its ranking by demonstrating success in the following areas:
    Developing and offering the most advanced therapies and innovative clinical trials.
  • Experts at Perlmutter Cancer Center have also implemented screening approaches to diagnose lung cancer in non-smokers.

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023

Retrieved on: 
Donnerstag, März 21, 2024
Research, Common stock, Ovarian cancer, IHC, Head, Therapeutic index, NSCLC, Immunotherapy, HNSCC, Patient, Neoplasm, Cohort, Tumor microenvironment, Observation, DESC, PDAC, Lung cancer, DLT, Investment, Clinical trial, Cancer, PIPE, ATM, Safety, Pharmacokinetics, Therapy, ADC, FACT, Pharmaceutical industry

BOSTON, March 21, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today reported financial results for the year and quarter ended December 31, 2023, and provided a corporate update.

Key Points: 
  • BOSTON, March 21, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today reported financial results for the year and quarter ended December 31, 2023, and provided a corporate update.
  • Approximately 54% of subjects have experienced grade 2, and 6% of subjects have experienced grade 3 treatment emergent adverse events (TEAEs).
  • As of December 31, 2023, Pyxis Oncology had cash and cash equivalents, including restricted cash, and short-term investments of $120.8 million.
  • As of March 20, 2024, the outstanding number of shares of Common Stock of Pyxis Oncology was 58,133,375.

The Law Offices of Frank R. Cruz Announces Investigation of Complete Solaria Inc. (CSLR) f/k/a Freedom Acquisition I Corporation (FACT) on Behalf of Investors

Retrieved on: 
Dienstag, April 2, 2024
Class Action Lawsuit, Professional Services, Legal, Suite, FACT, Law

The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Complete Solaria Inc. (“Complete Solaria” or “Company”) (NASDAQ: CSLR ) f/k/a Freedom Acquisition I Corp. (“FACT”) (NYSE: FACT, FACT WS) concerning whether the board breached its fiduciary duties to shareholders.

Key Points: 
  • The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Complete Solaria Inc. (“Complete Solaria” or “Company”) (NASDAQ: CSLR ) f/k/a Freedom Acquisition I Corp. (“FACT”) (NYSE: FACT, FACT WS) concerning whether the board breached its fiduciary duties to shareholders.
  • If you are a shareholder, click here to participate.
  • If you inquire by email please include your mailing address, telephone number and number of shares purchased.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Introducing RideFACTNOW: On-demand Wheelchair-Accessible Vehicle (WAV) Transportation Service Launches in San Diego County

Retrieved on: 
Dienstag, Oktober 24, 2023
Coordination, WAV, San Diego Association of Governments, Transport, Senior, Veteran, FACT, Quality of life, City, Common, San Diego County Board of Supervisors, SANDAG, Disability, SAN, Ridesharing, San Diegan (train)

SAN DIEGO, Oct. 24, 2023 /PRNewswire-PRWeb/ -- FACT (Facilitating Access to Coordinated Transportation) – a non-profit organization on a mission to improve mobility for individuals with disabilities, seniors, veterans, low income individuals, and other disadvantaged populations in San Diego County – recently launched a new essential transportation service: RideFACTNOW. In collaboration with SANDAG (San Diego Association of Governments), RideFACTNOW sets a groundbreaking precedent as one of only two programs of its kind in California – offering individuals with disabilities on-demand affordable, curb-to-curb transportation in wheelchair-accessible vehicles (WAV).

Key Points: 
  • RideFACTNOW sets a new standard for accessible transportation in the San Diego region as an on-demand service that's accessible to all 18 cities and most unincorporated areas.
  • The program stands out for its affordability and convenience, providing same-day service within the hour, for a flat rate of $10 per one-way ride throughout San Diego County.
  • "This service creates new, accessible ways for people to connect to opportunities and experiences," adds SANDAG and San Diego County Board Chair Nora Vargas.
  • This affordable, convenient solution will prove integral to the San Diego community in its commitment to ensuring equitable transportation services for San Diegans.

Shunt FACT Systems Lead Growth in the Global Flexible AC Transmission (FACT) Market, Expected to Reach $1.5 Billion by 2030 - ResearchAndMarkets.com

Retrieved on: 
Dienstag, Oktober 3, 2023
Energy, Other Energy, Utilities, System, Flexible AC transmission system, Flexible, Investment, FACT, Growth, Time-series segmentation, Electric power, Renewable energy

The "Flexible AC Transmission (FACT) Systems - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Flexible AC Transmission (FACT) Systems - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
  • The global market for Flexible AC Transmission (FACT) Systems was valued at approximately US$1.2 billion in 2022 and is projected to reach around US$1.9 billion by 2030, growing at a CAGR of 5.8% during the forecast period from 2022 to 2030.
  • FACT systems refer to technologies and equipment used in electrical power systems to enhance the efficiency, reliability, and stability of power transmission and distribution.
  • China: China is forecasted to experience significant growth in the FACT Systems market, with a projected market size of US$276 million by 2030.

Tiffany Pankratz-Umbehr, Head of SGS Maine Pointe's Consumer Goods & Retail Practice, is Recognized as a Recipient of the 2023 Women in Supply Chain Award

Retrieved on: 
Dienstag, September 19, 2023
Demand, Tiffany, Supply & Demand Chain Executive, Woman, 2023 Pro Bowl Games, SGS S.A., Consultant, Final good, Publication, Food, FACT, Development, Retail, Supply

PLYMOUTH, Mass., Sept. 19, 2023 /PRNewswire-PRWeb/ -- Global supply chain and operations implementation consulting firm, SGS Maine Pointe, a member of the SGS Group, announced today that Tiffany Pankratz-Umbehr, Head of Consumer Goods and Retail, has been honored by Supply & Demand Chain Executive magazine, as one of this year's winners of the Women in Supply Chain Award. More than 400 nomination submissions were received for the award.

Key Points: 
  • PLYMOUTH, Mass., Sept. 19, 2023 /PRNewswire-PRWeb/ -- Global supply chain and operations implementation consulting firm, SGS Maine Pointe , a member of the SGS Group , announced today that Tiffany Pankratz-Umbehr, Head of Consumer Goods and Retail, has been honored by Supply & Demand Chain Executive magazine, as one of this year's winners of the Women in Supply Chain Award.
  • This recognition means a lot not only to me personally, but to all women involved in supply chain management.
  • The prestigious award honors female supply chain leaders and executives whose accomplishments, mentorship and examples set a foundation for women in all levels of a company's supply chain network.
  • Recipients will be honored at this year's Women in Supply Chain Forum, set to take place Nov. 14-15, 2023 in Atlanta.

Pyxis Oncology Successfully Completes Acquisition of Apexigen

Retrieved on: 
Mittwoch, August 23, 2023
P.C, Therapy, Par value, Vassar College, Pfizer, Sidley Austin, Antibody, Research and development, Development, Acquisition, Patient, Oncology nursing, CD40, Ladenburg Thalmann, Cancer, Conjugation, FACT, ADC, Wilson Sonsini Goodrich & Rosati, Antibody-drug conjugate, Cornell University, Fine chemical, Management, New York University, Philosophy

BOSTON, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS) (“Pyxis Oncology” or the “Company”), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today announced the successful completion of its acquisition of Apexigen, Inc. (“Apexigen”), a clinical-stage biopharmaceutical company focused on discovering and developing innovative antibody therapeutics for oncology, in an all-stock transaction valued at approximately $10.7 million. The combined company is positioned at the forefront of ADC innovation with a platform that now includes four key components: novel humanized antibody generation capabilities, an expanded library of linkers with improved stability, site specific conjugation chemistries, and optimized payloads.

Key Points: 
  • Xiaodong Yang, M.D., Ph.D., founder and former Chief Executive Officer of Apexigen, is joining the combined company as Distinguished Research Fellow.
  • With the closing of this transaction, Jakob Dupont, M.D., Executive Partner at Sofinnova Investments, was appointed as an Independent Director to the Pyxis Oncology Board of Directors.
  • “I’m pleased to join the Pyxis Oncology Board of Directors,” said Jakob Dupont.
  • Pyxis Oncology issued approximately 4.3 million shares of common stock as a result of this transaction, and immediately post-acquisition, Pyxis Oncology is expected to have 43,872,248 shares of common stock outstanding.